FSD Pharma Inc.
HUGE · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,352 | -$2,091 | -$1,697 | -$1,131 |
| Dep. & Amort. | $137 | $120 | $126 | $147 |
| Deferred Tax | $0 | $0 | $186 | $6 |
| Stock-Based Comp. | $112 | $0 | $99 | $126 |
| Change in WC | $2,325 | -$556 | $733 | $1,146 |
| Other Non-Cash | $173 | $496 | -$336 | -$2,006 |
| Operating Cash Flow | -$606 | -$1,965 | -$888 | -$1,713 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$22 | -$2 | -$745 |
| Inv. Sales/Matur. | $0 | $0 | $1 | $443 |
| Other Inv. Act. | $738 | -$0 | $0 | $32 |
| Investing Cash Flow | $738 | -$22 | -$1 | -$270 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1 | $272 | -$25 | -$55 |
| Stock Issued | $1,843 | $296 | $0 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $2 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $1,845 | $569 | -$32 | -$55 |
| Forex Effect | $0 | $0 | $47 | $2,034 |
| Net Chg. in Cash | $1,976 | -$1,414 | -$874 | -$2,037 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,330 | $2,743 | $3,616 | $5,671 |
| End Cash | $3,307 | $1,329 | $2,743 | $3,634 |
| Free Cash Flow | -$606 | -$1,965 | -$888 | -$1,713 |